tanshinone has been researched along with Cancer of Prostate in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Che, B; Huang, T; Li, W; Tang, K; Xu, S; Yu, Y; Zhang, W | 1 |
| Chen, X; Ju, G; Ju, X; Xu, D; Yuan, J; Zhang, T; Zhang, Z; Zhou, J | 1 |
| Sun, G; Sun, J; Sun, K | 1 |
| Hou, LL; Hu, GQ; Xie, SQ; Xu, QJ | 1 |
| Chen, SP; Chiu, SC; Chiu, TL; Huang, SY; Pang, CY; Su, CC | 1 |
| Choi, JU; Jeong, M; Kim, B; Kim, MJ; Kim, SH; Shin, EA; Sohn, EJ; Won, G | 1 |
| Li, HZ; Lin, MC; Liu, CM; Qian, BJ; Yao, Y; Zhang, JB | 1 |
| Han, X; Li, B; Li, C; Wu, J; Zhang, H | 1 |
| Brégier, F; Chaleix, V; Granet, R; Leger, DY; Liagre, B; Mbakidi, JP; Micallef, L; Pouget, C; Qiu, S; Sol, V; Sothea-Ouk, T | 1 |
| Abdolmaleky, H; Blackburn, GL; Gong, Y; Li, L; Li, Y; Lu, Y; Zhou, JR | 1 |
| Choi, SH; Jeong, SJ; Jung, DB; Kim, SH; Kwon, TR; Lee, EO; Lee, HJ; Lee, MH; Lü, J; Shin, JM; Won, SH; Yun, SM | 1 |
| Jeong, SJ; Kim, SH; Lee, HJ; Lü, J; Won, SH | 1 |
| Geng, G; Liu, W; Sauriol, F; Shi, Q; Wu, JH; Zhou, J | 1 |
| Jeong, SJ; Jiang, C; Kim, SH; Lee, EO; Lee, HJ; Lü, J; Won, SH; Ye, M; Zhang, J; Zhang, Y | 1 |
1 review(s) available for tanshinone and Cancer of Prostate
| Article | Year |
|---|---|
Molecular Mechanism of Tanshinone against Prostate Cancer.
Topics: Abietanes; Androgens; Cell Line, Tumor; Humans; Male; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2022 |
13 other study(ies) available for tanshinone and Cancer of Prostate
| Article | Year |
|---|---|
PPARG is a potential target of Tanshinone IIA in prostate cancer treatment: a combination study of molecular docking and dynamic simulation based on transcriptomic bioinformatics.
Topics: Humans; Male; Molecular Docking Simulation; PPAR gamma; Prostatic Neoplasms; Transcriptome | 2023 |
Combination prostate cancer therapy: Prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone.
Topics: Abietanes; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Doxorubicin; Drug Carriers; Drug Combinations; Drug Liberation; Drug Stability; Female; Humans; Hydrogen-Ion Concentration; Lipids; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size; Prostatic Neoplasms; Random Allocation; Surface Properties; Xenograft Model Antitumor Assays | 2021 |
[Synergistic antitumor effects of tanshinone II A in combination with cisplatin via apoptosis in the prostate cancer cells].
Topics: Abietanes; Androgens; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Synergism; Drugs, Chinese Herbal; Humans; Male; Plant Roots; Plants, Medicinal; Prostatic Neoplasms; Salvia miltiorrhiza | 2013 |
Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drugs, Chinese Herbal; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; G1 Phase Cell Cycle Checkpoints; Humans; Male; Mitochondria; Prostatic Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Upregulation of microRNA135a-3p and death receptor 5 plays a critical role in Tanshinone I sensitized prostate cancer cells to TRAIL induced apoptosis.
Topics: Abietanes; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Drug Synergism; Humans; Male; MicroRNAs; Prostatic Neoplasms; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand; Transfection; Up-Regulation | 2014 |
[Crypotanshione reduces the expression of metadherin in DU145 prostate cancer cells].
Topics: Abietanes; Apoptosis; Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drugs, Chinese Herbal; Humans; In Situ Nick-End Labeling; Male; Membrane Proteins; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; RNA-Binding Proteins; RNA, Messenger; Signal Transduction; Time Factors | 2015 |
The interplay between autophagy and apoptosis induced by tanshinone IIA in prostate cancer cells.
Topics: Abietanes; Acetylcysteine; Adenocarcinoma; Amino Acid Chloromethyl Ketones; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Beclin-1; Caspase 3; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Male; Microtubule-Associated Proteins; Neoplasm Proteins; Prostatic Neoplasms; Reactive Oxygen Species | 2016 |
Delivery of tanshinone IIA and α-mangostin from gold/PEI/cyclodextrin nanoparticle platform designed for prostate cancer chemotherapy.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cyclodextrins; DNA Fragmentation; Drug Delivery Systems; Gold; Humans; Male; Microscopy, Electron, Transmission; Nanoparticles; Polyethyleneimine; Prostatic Neoplasms; Xanthones | 2016 |
Bioactive tanshinones in Salvia miltiorrhiza inhibit the growth of prostate cancer cells in vitro and in mice.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Aurora Kinase A; Aurora Kinases; Blotting, Western; Cell Adhesion; Cell Cycle; Cell Movement; Cell Proliferation; Humans; Immunoenzyme Techniques; In Vitro Techniques; Male; Mice; Mice, SCID; Phenanthrenes; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Salvia miltiorrhiza; Tumor Cells, Cultured | 2011 |
Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway.
Topics: 1-Phosphatidylinositol 4-Kinase; Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; Caspases; Cell Line, Tumor; DNA; Dose-Response Relationship, Drug; Enzymes; Humans; Male; Membrane Potential, Mitochondrial; Mitochondria; Phosphorylation; Phytotherapy; Plant Extracts; Plant Roots; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Salvia miltiorrhiza; Signal Transduction | 2010 |
Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells.
Topics: Abietanes; Androgen Receptor Antagonists; Antineoplastic Agents, Phytogenic; Cell Proliferation; Down-Regulation; G1 Phase Cell Cycle Checkpoints; Humans; Male; Plant Roots; Prostate; Prostatic Neoplasms; Receptors, Androgen; RNA, Small Interfering; Salvia miltiorrhiza; Signal Transduction; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2012 |
Antiandrogenic, maspin induction, and antiprostate cancer activities of tanshinone IIA and its novel derivatives with modification in ring A.
Topics: Abietanes; Androgen Antagonists; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Humans; Male; Mutation; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Serpins; Structure-Activity Relationship; Transcriptional Activation | 2012 |
Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling.
Topics: Abietanes; Active Transport, Cell Nucleus; Androgen Antagonists; Anilides; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Phenanthrenes; Prostate-Specific Antigen; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Receptors, Androgen; RNA, Messenger; Salvia miltiorrhiza; Signal Transduction; Time Factors; Tosyl Compounds; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |